Running Point Capital Advisors’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Running Point Capital Advisors’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,000	Closed	-$34.5K	–	210
2022 Q4	$34.5K	Hold	10,000	–	–	0.02%	169
2022 Q3	$26K	Hold	10,000	–	–	0.02%	176
2022 Q2	$24K	Hold	10,000	–	–	0.02%	182
2022 Q1	$41K	Buy	+10,000	New	+$53K	0.02%	165

Other funds holding GRTS

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Running Point Capital Advisors's GRTS Position: Q1 2023 in Review

Running Point Capital Advisors sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q1 2023, closing a stake of 10,000 shares — an estimated $34.5K sold.

Running Point Capital Advisors first reported a position in GRTS in Q1 2022 and held it in 4 quarters. The position peaked at $41K in Q1 2022. 90 funds tracked by Wall St. Rank hold GRTS as of Q1 2023.

Running Point Capital Advisors reported no remaining Gritstone bio, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Running Point Capital Advisors sold 10,000 Gritstone bio, Inc. Common Stock shares in Q1 2023, an estimated $34.5K.
Running Point Capital Advisors first reported a position in Gritstone bio, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
Running Point Capital Advisors's Gritstone bio, Inc. Common Stock position peaked at $41K in Q1 2022.
90 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q1 2023.

Based on Running Point Capital Advisors's 13F filing for Q1 2023, filed 10 May 2023.